In vitro behaviour of sesquiterpene lactones and sesquiterpene lactone-containing plant preparations in human blood, plasma and human serum albumin solutions

Planta Medica

Volumn 70, Issue 3, 2004, Pages 227-233

  Wagner, Steffen ^a   Kratz, Felix ^b   Merfort, Irmgard ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b TUMOR BIOLOGY CENTER   (Germany)

Author keywords

Arnica montana; Asteraceae; Bioavailability; Human serum albumin; Plasma; Protein binding; Sesquiterpene lactone; Tanacetum parthenium; Whole blood

Indexed keywords

AMINO ACID; CYSTEINE; DIHYDROHELENALIN ACETATE; DIHYDROHELENALIN METHACRYLATE; HELENALIN ISOBUTYRATE; HUMAN SERUM ALBUMIN; PARTHENOLIDE; PLASMA PROTEIN; PROTEIN; SESQUITERPENE LACTONE DERIVATIVE; THIOL GROUP; UNCLASSIFIED DRUG;

ARNICA MONTANA; ARTICLE; BLOOD; FEMALE; GAS CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MALE; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; PHOTOMETRY; PLASMA; PROTEIN BINDING; TANACETUM PARTHENIUM;

ARNICA; BIOLOGICAL AVAILABILITY; BLOOD PROTEINS; FEMALE; HUMANS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PLASMA; PROTEIN BINDING; SERUM ALBUMIN; SESQUITERPENES; TANACETUM PARTHENIUM;

ARNICA; ARNICA MONTANA; ASTERACEAE; PARTHENIUM; TANACETUM; TANACETUM PARTHENIUM;

EID: 1842484340     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-815539     Document Type: Article

References (21)

1. Schmidt TJ. Toxic activities of sesquiterpene lactones: Structural and biochemical aspects. Curr Org Chem 1999; 3: 577-608
2. Schmidt TJ. Helenanolide-type sesquiterpene lactones - III. Rates and stereochemistry in the reaction of helenalin and related helenanolides with sulfhydryl containing biomolecules. Bioorg Med Chem 1997; 5: 645-53
3. Ruengeler P, Castro V, Mora G, Goren N, Vichnewski W, Pahl HL et al. Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action. Bioorg Med Chem 1999; 7: 2343-52
4. Humar M, García-Pineres AJ, Castro V, Merfort I. Effect of sesquiterpene lactones on the expression of the activation marker CD69 and of IL-2 in T-lymphocytes in whole blood. Biochem Pharmacol 2003; 65: 1551-63
5. 3H]-plenolin, in BDF1 mice. Planta Med 1991; 57: 309-14
6. Hill DW, Bailey EM, Camp BJ. Tissue distribution and disposition of hymenoxon. J Agric Food Chem 1980; 28: 1269-73
7. Knight DW. Feverfew: chemistry and biological activity. Nat Prod Rep 1995; 12: 271-6
8. Fischer NH, Lu T, Cantrell CL, Castaneda-Acosta J, Quijano L, Franzblau SG. Antimycobacterial evaluation of germacranolides. Phytochemistry 1998; 49: 559-64
9. Knuesel O, Weber M, Suter A. Arnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial. Adv Ther 2002; 19: 209-18
10. Willuhn G. Arnica flowers: Pharmacology, toxicology and analytics of the sesquiterpene lactones - their main active substances. In: Lawson LD, Bauer R (editors). Phytomedicines of Europe. Washington: American Chemical Society, 1996: p 118-32
11. Willuhn G, Leven W. On the qualitative and quantitative analysis of the sesquiterpene lactones of Arnicae flos DAB 9. PZ (Pharmazeutische Zeitung) Wissenschaft 1991; 136: 32-9
12. Thomas L. Labor und Diagnose: Indikation und Bewertung von Laborbefunden für die Medizinische Diagnostik; 5 ed Frankfurt/Main: TH-Books, 1998
13. Ellman GL. A colorimetric method for determining low concentrations of mercaptans. Arch Biochem Biophys 1958; 74: 443-50
14. Peters T Jr. Serum albumin. Adv Protein Chem 1985; 37: 161-245
15. Kratz F, Warnecke A, Scheuermann K, Stockmar C, Schwab J, Lazar P et al. Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound. J Med Chem 2002; 45: 5523-33
16. Schmidt TJ, Lyss G, Pahl HL, Merfort I. Helenanolide type sesquiterpene lactones. Part 5: the role of glutathione addition under physiological conditions. Bioorg Med Chem 1999; 7: 2849-55
17. Hausen BM, Vieluf IK. Allergiepflanzen, Pflanzenallergene. Landsberg, München: Ecomed Verlagsgesellschaft, 1997
18. Benard O, Balasubramanian KA. Effect of oxidant exposure on thiol status in the intestinal mucosa. Biochem Pharmacol 1993; 45: 2011-5
19. Adamowicz A, Trafikowska U, Trafikowska A, Zachara B, Manitius J. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis. Med Sci Monit 2002; 8: 202-5
20. Heptinstall S, Groenewegen WA, Spangenberg P, Loesche W. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups. J Pharm Pharmacol 1987; 39: 459-65
21. 13C NMR. Bioorg Med Chem 1993; 1: 389-97